METHODS OF TREATING TUMORS

The disclosure provides pharmaceutical compositions comprising an anti-PD-1 antibody or an anti-PD-LI antibody formulated for subcutaneous delivery, wherein the pharmaceutical compositions further comprise an endoglycosidase hydrolase enzyme such as a hyaluronidase. La divulgation concerne des compo...

Full description

Saved in:
Bibliographic Details
Main Authors ZHAO, XIAOCHEN, HABY, THOMAS ARTHUR, KHOSSRAVI, MEHRNAZ, ROY, AMIT, MURTHY, BINDU PURNIMA, ARAS, URVI ASHISH, MANTRI, RAO VENKATRAMANA, VEZINA, HEATHER ELIZABETH, HUANG, MASANO, SANGHAVI, KINJAL, HART, SCOTT AARON, BELLO, AKINTUNDE
Format Patent
LanguageEnglish
French
Published 07.07.2022
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The disclosure provides pharmaceutical compositions comprising an anti-PD-1 antibody or an anti-PD-LI antibody formulated for subcutaneous delivery, wherein the pharmaceutical compositions further comprise an endoglycosidase hydrolase enzyme such as a hyaluronidase. La divulgation concerne des compositions pharmaceutiques comprenant un anticorps anti-PD-1 ou un anticorps anti-PD-L1 formulé pour une administration sous-cutanée, les compositions pharmaceutiques comprenant en outre une enzyme endoglycosidase hydrolase telle qu'une hyaluronidase.
Bibliography:Application Number: CA20213196999